13F Pro Quality Score

48.6/100

Rank #1,550 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

44.8/100

Profitability

64.9/100

Balance Sheet

66.3/100

Earnings Quality

23.5/100

Free Cash Flow

50.9/100

Institutional Flow

9.2/100

Revenue Scale

17.9/100

Dilution Risk

94.9/100

FONR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for FONAR CORP (FONR), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FONR at 48.6/100 on a 32-signal composite quality model, placing it at rank #1,550 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (9.2) and revenue scale (17.9), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q3 2026), FONAR CORP reports quarterly revenue of $26.5M, net income of $1.6M, an operating margin of 10.7%. Top institutional holders of FONR by reported 13-F value include MONEY CONCEPTS CAPITAL, VANGUARD CAPITAL MANAGEMENT, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. FONR trades on the Nasdaq exchange and files with the SEC under CIK 355019. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FONR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for FONAR CORP directly from SEC EDGAR. FONAR CORP's 13F Pro composite quality score has ranged between 45 and 68 since 2021, currently 48.6 — a declining long-term trajectory across 28 quarterly and live scoring snapshots.

Fun facts about FONAR CORP

Quirks, history, and lore behind FONR — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    A small-cap U.S. healthcare company listed on Nasdaq, headquartered on Long Island, New York.
  • 2
    The Numbers
    Annual revenue in the range of tens of millions of dollars — a true micro-niche player — with a focus on a single medical imaging technology.
  • 3
    The History
    Founded in the 1970s, it was a pioneering force in bringing a revolutionary diagnostic imaging technology out of the lab and into clinical medicine.
  • 4
    The Secret
    Its founder holds patents considered foundational to the entire MRI industry — and the company spent years in patent litigation against much larger rivals.
  • 5
    The Lore
    It claims to have built and installed the world's first commercial MRI scanner, and its founder, Raymond Damadian, famously believed he deserved a Nobel Prize for inventing MRI.
  • 6
    The Giveaway
    This Long Island company literally has MRI baked into its DNA — its name is a portmanteau of "field focusing nuclear magnetic resonance" — and it's still scanning decades later.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q3 2026

$26.5M

Net Income

Q3 2026

$1.6M

Free Cash Flow

Q3 2026

$1.4M

Operating Margin

Q3 2026

10.7%

ROIC

Q3 2026

1.6%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+1.4% YoY
$104.4MFY 2025
FY21 $89.9MFY23 $98.6MFY24 $102.9MFY25 $104.4M

Net Income

-21.1% YoY
$8.3MFY 2025
FY21 $10.2MFY23 $9.4MFY24 $10.6MFY25 $8.3M

Operating Income

FY 2025
FY21 $-7.1MFY23 $11.1MFY24 $4.5MFY25

Total Assets

+1.2% YoY
$216.9MFY 2025
FY21 $189.5MFY23 $200.6MFY24 $214.2MFY25 $216.9M

Total Debt

FY 2025
FY21 $1.9MFY23 $246.6KFY24 $207.9KFY25

Op. Cash Flow

-20.1% YoY
$11.3MFY 2025
FY21 $19.1MFY23 $14.5MFY24 $14.1MFY25 $11.3M

AI Insight: FONR Financial Trends

FONAR carries zero debt and steadily grows equity to $179M, but revenue and earnings remain range-bound with no clear growth catalyst visible.

Revenue has stayed flat between $24M–$27M across every reported quarter from Q1 2024 through Q1 2026.

Equity has grown consistently from $166M in Q1 2024 to $179M in Q1 2026, a $13M cumulative increase.

Total debt has remained at $0M throughout the entire observation period, reflecting a clean balance sheet.

Net income is volatile quarter-to-quarter ($1M–$3M), suggesting inconsistent earnings conversion despite stable revenue.

Operating cash flow dipped to $2M in Q1 2026, matching the weakest readings in the dataset.

Operating income is absent across all periods — without it, margin structure and cost trends remain opaque.

AI Insight: FONR Ratio Trends

FONAR's profitability shows persistent seasonal weakness in Q2 and a step-down in Q1 2026, with ROIC contracting to 6.3% — its lowest ex-Q2 reading in the observed period.

Operating margin fell to 10.7% in Q1 2026 from 15.2% in Q1 2025, a 4.5pp year-over-year decline.

ROIC dropped to 6.3% in Q1 2026 versus 9.6% in Q1 2025 and 10.4% in Q1 2024, a clear downward step.

Debt/Equity remains 0.00 across all reported quarters, signaling a completely unlevered balance sheet.

Q2 quarters consistently show margin troughs: OpMargin of 7.4% in Q2 2024 and 5.2% in Q2 2025, suggesting strong seasonality.

Q1 2026 OpMargin of 10.7% is the weakest non-Q2 quarter in the dataset — monitor whether this marks structural deterioration.

NPM compressed to 6.2% in Q1 2026 vs. 9.2% in Q1 2025; cost pressures or revenue softness driving the gap warrant scrutiny.

Get alerted when FONR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for FONAR CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put FONR on your watchlist

Track score changes the day FONAR CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is FONR a good stock to buy?

13F Pro's AI-powered analysis of FONAR CORP (FONR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for FONR are available on the FONR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own FONR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling FONR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of FONAR CORP's investment landscape.